Since knocking out Olfr2 reduces atherosclerosis, Olfr2 and, by extension, OR6A2, are potential therapeutic targets for the prevention and treatment of atherosclerosis (Figure 3). The gene discussed is OR2H2; the disease is atherosclerosis.